JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Molecular mechanisms of pancreatic cancer liver metastasis: the role of PAK2

  • 0Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
Frontiers in Immunology +

|

February 12, 2024

|

February 12, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

This study identifies PAK2 as a key gene driving pancreatic cancer liver metastasis by activating TGF-beta signaling and promoting epithelial-mesenchymal transition. Targeting PAK2 may offer new therapeutic strategies for pancreatic cancer patients.

Area Of Science

  • Oncology
  • Molecular Biology
  • Genomics

Background

  • Pancreatic cancer is a highly lethal malignancy with poor prognosis, especially upon metastasis.
  • Liver metastasis is the most common metastatic site for pancreatic cancer, significantly impacting treatment planning and patient outcomes.

Purpose Of The Study

  • To elucidate the molecular mechanisms underlying pancreatic cancer liver metastasis.
  • To identify key genes and pathways involved in pancreatic cancer liver metastasis.
  • To provide a scientific basis for developing novel therapeutic strategies and drugs.

Main Methods

  • Utilized single-cell and bulk sequencing data (GSE155698, GSE154778, GSE71729, GSE19279, TCGA-PAAD).
  • Employed Seurat, hdWGCNA, machine learning, and COX regression to identify liver metastasis-related genes (LRGs).
  • Analyzed signaling pathways (GSVA), cell differentiation (pseudo-temporal), cell communication, transcription factor activity, drug sensitivity, and metabolic pathways. Performed functional experiments (gene silencing).

Main Results

  • Identified PAK2 as a critical gene promoting pancreatic cancer liver metastasis.
  • PAK2 activates the TGF-beta signaling pathway, reduces cancer cell differentiation, and enhances cell communication with the tumor microenvironment.
  • Silencing PAK2 decreased cancer cell proliferation, invasion, and apoptosis, while impacting gemcitabine resistance and metabolic pathways.

Conclusions

  • PAK2 promotes pancreatic cancer liver metastasis by enhancing angiogenesis, epithelial-mesenchymal transition (EMT), chemoresistance, and metabolic reprogramming.
  • PAK2 plays a pivotal role in orchestrating pancreatic cancer liver metastasis.
  • Targeting PAK2 presents a potential therapeutic strategy to prevent liver metastasis and improve outcomes in pancreatic cancer.

Keywords:

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway 01:22

3.6K

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...

mTOR Signaling and Cancer Progression 03:03

3.8K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Interactions Between Signaling Pathways 01:19

6.3K

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

MAPK Signaling Cascades 01:07

5.5K

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Metastasis 02:30

5.5K

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Cancer Cell Migration through Invadopodia 01:35

2.3K

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...